Telmisartan/hctz 40-12.5mg Tabs

Manufacturer ALEMBIC PHARMACEUTICALS Active Ingredient Telmisartan and Hydrochlorothiazide(tel mi SAR tan & hye droe klor oh THYE a zide) Pronunciation tel mi SAR tan & hye droe klor oh THYE a zide
WARNING: Do not take if you are pregnant. Use during pregnancy may cause birth defects or loss of the unborn baby. If you get pregnant or plan on getting pregnant while taking this drug, call your doctor right away. @ COMMON USES: It is used to treat high blood pressure.
🏷️
Drug Class
Antihypertensive
🧬
Pharmacologic Class
Angiotensin II Receptor Blocker (ARB) / Thiazide Diuretic Combination
🤰
Pregnancy Category
Category D
FDA Approved
Apr 2000
⚖️
DEA Schedule
Not Controlled

Overview

ℹ️

What is this medicine?

This medication is a combination of two drugs: telmisartan and hydrochlorothiazide. Telmisartan helps relax blood vessels, and hydrochlorothiazide is a 'water pill' that helps your body get rid of extra salt and water. Together, they work to lower your blood pressure, which can help prevent strokes, heart attacks, and kidney problems.
📋

How to Use This Medicine

Taking Your Medication Correctly

To get the most benefit from your medication, take it exactly as directed by your doctor. Carefully read all the information provided with your prescription, and follow the instructions closely. You can take this medication with or without food. Continue taking the medication as prescribed by your doctor or healthcare provider, even if you start to feel better.

It's essential to drink plenty of non-caffeinated fluids, unless your doctor advises you to limit your fluid intake. Be aware that this medication may increase the frequency of urination. To minimize sleep disturbances, try to avoid taking the medication too close to bedtime. Establish a routine by taking the medication at the same time every day.

Some brands of this medication are packaged in blister packs. If your medication comes in a blister pack, remove the tablet from the pack immediately before taking it. To do this, peel back the foil on the blister pack, but avoid pushing the tablet through the foil, as this may cause it to break.

Storing and Disposing of Your Medication

Store your medication in its original container at room temperature, in a dry location, and away from the bathroom. Keep all medications in a safe place, out of the reach of children and pets.

What to Do If You Miss a Dose

If you miss a dose, take it as soon as you remember. However, if it's close to the time for your next scheduled dose, skip the missed dose and resume your regular dosing schedule. Do not take two doses at the same time or take extra doses to make up for the missed one.
💡

Lifestyle & Tips

  • Take this medication exactly as prescribed, usually once daily with or without food.
  • Do not stop taking this medication without talking to your doctor, even if you feel well.
  • Continue to follow a low-sodium (low-salt) diet as recommended by your doctor or dietitian.
  • Engage in regular physical activity as advised by your healthcare provider.
  • Limit alcohol intake, as it can further lower blood pressure.
  • Avoid potassium supplements or salt substitutes containing potassium unless directed by your doctor, as this medication can affect potassium levels.
  • Stay well-hydrated, especially during hot weather or exercise, to prevent dehydration, but avoid excessive fluid intake unless advised by your doctor.

Dosing & Administration

👨‍⚕️

Adult Dosing

Standard Dose: One 40 mg/12.5 mg tablet orally once daily
Dose Range: 40 - 80 mg

Condition-Specific Dosing:

hypertension: Initial dose is typically 40 mg/12.5 mg once daily. May be titrated up to 80 mg/25 mg once daily if blood pressure is not adequately controlled after 2-4 weeks. The 40 mg/12.5 mg strength is for patients whose blood pressure is not adequately controlled with telmisartan monotherapy or hydrochlorothiazide monotherapy.
👶

Pediatric Dosing

Neonatal: Not established
Infant: Not established
Child: Not established
Adolescent: Not established
⚕️

Dose Adjustments

Renal Impairment:

Mild: No dosage adjustment required for CrCl > 30 mL/min.
Moderate: No dosage adjustment required for CrCl > 30 mL/min. Use with caution.
Severe: Contraindicated for patients with anuria or severe renal impairment (CrCl ≤ 30 mL/min) due to the hydrochlorothiazide component.
Dialysis: Contraindicated. Hydrochlorothiazide is not effective in patients with severe renal impairment.

Hepatic Impairment:

Mild: For telmisartan, maximum dose is 40 mg once daily. For the combination, use with caution.
Moderate: For telmisartan, maximum dose is 40 mg once daily. For the combination, use with caution.
Severe: Contraindicated due to the telmisartan component, which is primarily eliminated via bile.

Pharmacology

🔬

Mechanism of Action

Telmisartan is an angiotensin II receptor blocker (ARB) that selectively blocks the binding of angiotensin II to the AT1 receptor in many tissues, including vascular smooth muscle and the adrenal gland. This inhibits the vasoconstrictor and aldosterone-secreting effects of angiotensin II, leading to vasodilation, reduced peripheral resistance, and decreased blood pressure. Hydrochlorothiazide is a thiazide diuretic that inhibits sodium and chloride reabsorption in the distal convoluted tubule, leading to increased excretion of sodium, chloride, and water, and to a lesser extent, potassium and magnesium. This reduces plasma volume and peripheral vascular resistance, contributing to its antihypertensive effect.
📊

Pharmacokinetics

Absorption:

Bioavailability: Telmisartan: 42-58% (dose-dependent); Hydrochlorothiazide: 50-80%
Tmax: Telmisartan: 0.5-1 hour; Hydrochlorothiazide: 1-2.5 hours
FoodEffect: Telmisartan: Food slightly reduces bioavailability (up to 6% for 40mg dose), but not clinically significant. Hydrochlorothiazide: Food may increase absorption.

Distribution:

Vd: Telmisartan: Approximately 500 L; Hydrochlorothiazide: 0.8-1.7 L/kg
ProteinBinding: Telmisartan: >99.5%; Hydrochlorothiazide: 40-68%
CnssPenetration: Telmisartan: Limited; Hydrochlorothiazide: Limited

Elimination:

HalfLife: Telmisartan: Approximately 24 hours; Hydrochlorothiazide: 5.6-14.8 hours
Clearance: Telmisartan: Approximately 1000 mL/min; Hydrochlorothiazide: Renal clearance is 250-300 mL/min
ExcretionRoute: Telmisartan: Primarily fecal (biliary excretion); Hydrochlorothiazide: Renal (unchanged)
Unchanged: Telmisartan: <1% in urine; Hydrochlorothiazide: >95% in urine
⏱️

Pharmacodynamics

OnsetOfAction: Telmisartan: Within 3 hours; Hydrochlorothiazide: Within 2 hours
PeakEffect: Telmisartan: 4-8 weeks for full blood pressure reduction; Hydrochlorothiazide: 4 hours
DurationOfAction: Telmisartan: 24 hours; Hydrochlorothiazide: 6-12 hours

Safety & Warnings

⚠️

BLACK BOX WARNING

When pregnancy is detected, discontinue Telmisartan/Hydrochlorothiazide as soon as possible. Drugs that act directly on the renin-angiotensin system can cause injury and death to the developing fetus.
⚠️

Side Effects

Urgent Side Effects: Seek Medical Help Right Away

Although rare, some people may experience severe and potentially life-threatening side effects while taking this medication. If you notice any of the following symptoms, contact your doctor or seek medical attention immediately:

Signs of an allergic reaction, such as:
+ Rash or hives
+ Itching or red, swollen, blistered, or peeling skin (with or without fever)
+ Wheezing or tightness in the chest or throat
+ Difficulty breathing, swallowing, or talking
+ Unusual hoarseness
+ Swelling of the mouth, face, lips, tongue, or throat
Signs of kidney problems, including:
+ Inability to pass urine
+ Changes in urine output
+ Blood in the urine
+ Sudden weight gain
Signs of pancreatitis (pancreas problems), such as:
+ Severe stomach pain
+ Severe back pain
+ Severe upset stomach or vomiting
Signs of liver problems, including:
+ Dark urine
+ Fatigue
+ Decreased appetite
+ Upset stomach or stomach pain
+ Light-colored stools
+ Vomiting
+ Yellow skin or eyes
Signs of fluid and electrolyte problems, such as:
+ Mood changes
+ Confusion
+ Muscle pain or weakness
+ Abnormal heartbeat or fast heart rate
+ Severe dizziness or fainting
+ Increased thirst
+ Seizures
+ Feeling extremely tired or weak
+ Decreased appetite
+ Changes in urine output
+ Dry mouth
+ Dry eyes
+ Severe upset stomach or vomiting
Chest pain
Severe dizziness or fainting
Difficulty passing urine
Pain while passing urine
Fever, chills, or sore throat
Unexplained bruising or bleeding
Feeling extremely tired or weak
Abnormal sensations, such as burning, numbness, or tingling
Shortness of breath
Restlessness
Erectile dysfunction
Rarely, skin cancer has been reported in people taking hydrochlorothiazide. To minimize risk, protect your skin from the sun and follow your doctor's recommendations for skin checks. If you notice any changes in the color or size of a mole, or any new or changing skin lump or growth, contact your doctor immediately.

Other Possible Side Effects

Like all medications, this drug can cause side effects. While many people may not experience any side effects or only minor ones, it's essential to discuss any concerns with your doctor. If you experience any of the following side effects, contact your doctor or seek medical attention if they bother you or persist:

Common cold symptoms
Dizziness, fatigue, or weakness
Flu-like symptoms
Back pain
Diarrhea
* Upset stomach

This list is not exhaustive, and you may experience other side effects not mentioned here. If you have questions or concerns about side effects, consult your doctor. You can also report side effects to the FDA at 1-800-332-1088 or online at https://www.fda.gov/medwatch.
🚨

Seek Immediate Medical Attention If You Experience:

  • Severe dizziness or fainting (especially when standing up)
  • Unusual tiredness or weakness
  • Muscle cramps or pain
  • Nausea, vomiting, or excessive thirst
  • Swelling of the face, lips, tongue, or throat (signs of a severe allergic reaction called angioedema)
  • Difficulty breathing or swallowing
  • Decreased urination or swelling in your feet or ankles (signs of kidney problems)
  • Yellowing of the skin or eyes (jaundice)
  • Blurred vision or eye pain (rare, but can be signs of acute angle-closure glaucoma)
📋

Before Using This Medicine

Before Taking This Medication: Important Information to Share with Your Doctor

It is essential to inform your doctor about the following conditions to ensure safe treatment:

Any allergies you have, including allergies to this medication, its components, or other substances, such as foods or drugs. Describe the allergic reaction you experienced, including the symptoms that occurred.
A known sulfa allergy.
Certain health conditions, including:
+ Kidney disease
+ Liver disease
Dehydration or electrolyte imbalances.
Inability to urinate.
Current medications, particularly:
+ Aliskiren
+ Benazepril
+ Captopril
+ Enalapril
+ Fosinopril
+ Lisinopril
+ Moexipril
+ Perindopril
+ Quinapril
+ Ramipril
+ Trandolapril
+ Dofetilide
* If you are breast-feeding. Note: You should not breast-feed while taking this medication.

This list is not exhaustive, and it is crucial to discuss all your medications (prescription, over-the-counter, natural products, and vitamins) and health problems with your doctor and pharmacist. They will help determine if it is safe to take this medication with your other treatments and health conditions. Never start, stop, or adjust the dosage of any medication without consulting your doctor first.
⚠️

Precautions & Cautions

Important Warnings and Cautions

It is crucial that you inform all of your healthcare providers, including doctors, nurses, pharmacists, and dentists, that you are taking this medication.

Caution with Daily Activities
Until you know how this medication affects you, avoid driving and other tasks that require alertness. To minimize the risk of dizziness or fainting, stand up slowly after sitting or lying down, and be cautious when climbing stairs.

Managing Diabetes
If you have diabetes, closely monitor your blood sugar levels. Be aware of signs of high blood sugar, such as confusion, drowsiness, increased thirst or hunger, frequent urination, flushing, rapid breathing, or fruity-smelling breath. Report these symptoms to your doctor.

Monitoring Blood Pressure and Lab Tests
Check your blood pressure as directed by your healthcare provider. Additionally, have your blood work checked as scheduled, and discuss the results with your doctor. Note that this medication may affect certain lab tests, so inform all healthcare providers and lab personnel that you are taking this drug.

Interactions with Other Substances
If you are taking a salt substitute containing potassium, a potassium-sparing diuretic, or a potassium product, consult with your doctor. Also, discuss your diet with your doctor if you are on a low-salt or salt-free diet. Before using over-the-counter (OTC) products that may increase blood pressure, such as cough or cold medications, diet pills, stimulants, non-steroidal anti-inflammatory drugs (NSAIDs) like ibuprofen or naproxen, or certain natural products, consult with your doctor.

Caution with Other Medications and Substances
Before using alcohol, marijuana or other forms of cannabis, or prescription or OTC medications that may slow your reactions, discuss with your doctor.

Precautions in Hot Weather
In hot weather or during physical activity, drink plenty of fluids to prevent dehydration. If you experience excessive sweating, fluid loss, vomiting, or diarrhea, inform your doctor, as these conditions may lead to low blood pressure.

Eye Problems
This medication can cause certain eye problems, which, if left untreated, may result in permanent vision loss. If you experience eye problems, symptoms such as changes in vision or eye pain usually occur within hours to weeks of starting this medication. Seek medical attention immediately if you notice these symptoms.

Rare but Serious Reaction
In rare cases, a severe reaction called angioedema has occurred with this medication, which can be life-threatening. Seek medical help immediately if you experience symptoms such as swelling of the hands, face, lips, eyes, tongue, or throat, difficulty breathing or swallowing, or unusual hoarseness.

Cholesterol and Triglyceride Levels
This medication may increase cholesterol and triglyceride levels. Discuss this with your doctor. If you take cholestyramine or colestipol, consult with your pharmacist about how to take these medications with this drug. Be aware of the risk of gout attacks.

Lupus and Sun Sensitivity
If you have lupus, this medication may activate or worsen the condition. Inform your doctor immediately if you experience new or worsening symptoms. Additionally, this medication may increase your risk of sunburn. Take precautions when exposed to the sun, and inform your doctor if you experience increased sun sensitivity while taking this medication.
🆘

Overdose Information

Overdose Symptoms:

  • Profound hypotension (very low blood pressure)
  • Tachycardia (rapid heart rate)
  • Bradycardia (slow heart rate)
  • Dizziness
  • Lightheadedness
  • Dehydration
  • Electrolyte depletion (e.g., hypokalemia, hyponatremia)
  • Nausea
  • Vomiting
  • Lethargy

What to Do:

If you suspect an overdose, seek immediate medical attention. Call 911 or your local poison control center (1-800-222-1222 in the US). Treatment is supportive and symptomatic, focusing on maintaining blood pressure and fluid/electrolyte balance.

Drug Interactions

🚫

Contraindicated Interactions

  • Aliskiren (in patients with diabetes or renal impairment (GFR < 60 mL/min/1.73 m²))
🔴

Major Interactions

  • Lithium (increased serum lithium concentrations and toxicity)
  • NSAIDs (including COX-2 inhibitors - reduced antihypertensive effect, increased risk of renal impairment)
  • Potassium-sparing diuretics (e.g., spironolactone, triamterene, amiloride - increased risk of hyperkalemia)
  • Potassium supplements (increased risk of hyperkalemia)
  • ACE inhibitors (increased risk of hypotension, hyperkalemia, and renal impairment when co-administered with ARBs)
  • Digoxin (hydrochlorothiazide-induced hypokalemia can potentiate digoxin toxicity)
  • Corticosteroids (increased risk of electrolyte depletion, particularly hypokalemia)
  • Insulin and oral hypoglycemic agents (hydrochlorothiazide may decrease glucose tolerance, requiring dose adjustment of antidiabetic agents)
🟡

Moderate Interactions

  • Barbiturates, narcotics, or alcohol (additive hypotensive effect)
  • Cholestyramine and colestipol resins (impaired absorption of hydrochlorothiazide)
  • Pressor amines (e.g., norepinephrine - hydrochlorothiazide may decrease arterial responsiveness)
  • Non-depolarizing skeletal muscle relaxants (e.g., tubocurarine - hydrochlorothiazide may potentiate effect)
🟢

Minor Interactions

  • Allopurinol (increased risk of hypersensitivity reactions with hydrochlorothiazide)
  • Calcium salts (increased serum calcium levels due to decreased excretion by hydrochlorothiazide)

Monitoring

🔬

Baseline Monitoring

Blood Pressure (BP)

Rationale: To establish baseline and assess treatment efficacy.

Timing: Prior to initiation of therapy

Serum Electrolytes (Potassium, Sodium, Magnesium, Calcium)

Rationale: To establish baseline and identify pre-existing imbalances, especially potassium due to diuretic component.

Timing: Prior to initiation of therapy

Renal Function (BUN, Serum Creatinine, eGFR)

Rationale: To assess baseline renal function, as both components can affect kidney function and dose adjustments may be needed.

Timing: Prior to initiation of therapy

Liver Function Tests (LFTs)

Rationale: To assess baseline hepatic function, as telmisartan is primarily eliminated via bile and dose adjustments are needed in hepatic impairment.

Timing: Prior to initiation of therapy

Uric Acid

Rationale: Hydrochlorothiazide can increase uric acid levels.

Timing: Prior to initiation of therapy

Blood Glucose

Rationale: Hydrochlorothiazide can affect glucose metabolism.

Timing: Prior to initiation of therapy

📊

Routine Monitoring

Blood Pressure (BP)

Frequency: Regularly, e.g., weekly initially, then monthly or as clinically indicated

Target: <130/80 mmHg or individualized target

Action Threshold: If BP remains uncontrolled, consider dose titration or additional therapy. If hypotensive, consider dose reduction.

Serum Electrolytes (Potassium, Sodium)

Frequency: Within 1-2 weeks of initiation or dose change, then periodically (e.g., every 3-6 months) or as clinically indicated.

Target: Potassium: 3.5-5.0 mEq/L; Sodium: 135-145 mEq/L

Action Threshold: Hypokalemia (<3.5 mEq/L) or hyperkalemia (>5.5 mEq/L), hyponatremia (<130 mEq/L) require intervention.

Renal Function (BUN, Serum Creatinine, eGFR)

Frequency: Within 1-2 weeks of initiation or dose change, then periodically (e.g., every 3-6 months) or as clinically indicated, especially in patients with pre-existing renal impairment or those on concomitant NSAIDs.

Target: Stable creatinine, eGFR > 60 mL/min/1.73 m²

Action Threshold: Significant increase in creatinine or decrease in eGFR (e.g., >30% from baseline) may require dose adjustment or discontinuation.

Uric Acid

Frequency: Periodically, especially in patients with a history of gout.

Target: Within normal limits

Action Threshold: Significant elevation or symptoms of gout.

Blood Glucose

Frequency: Periodically, especially in diabetic patients.

Target: Individualized glycemic targets

Action Threshold: Significant hyperglycemia.

👁️

Symptom Monitoring

  • Dizziness or lightheadedness (especially upon standing, indicative of hypotension)
  • Fatigue or weakness
  • Muscle cramps or weakness (signs of electrolyte imbalance, particularly hypokalemia)
  • Dry mouth, thirst, nausea, vomiting (signs of dehydration or electrolyte imbalance)
  • Swelling of face, lips, tongue, or throat (signs of angioedema, rare but serious)
  • Difficulty breathing or swallowing (signs of angioedema)
  • Changes in urination (e.g., decreased urine output, signs of renal dysfunction)
  • Unusual bruising or bleeding (rare, but possible blood dyscrasias with HCTZ)
  • Yellowing of skin or eyes (jaundice, rare, but possible hepatic issues)

Special Patient Groups

🤰

Pregnancy

Contraindicated during the second and third trimesters of pregnancy due to the risk of fetal injury and death. Discontinue as soon as pregnancy is detected. Use in the first trimester is generally not recommended due to potential risks.

Trimester-Specific Risks:

First Trimester: Limited human data, but potential for fetal harm cannot be excluded. Category C.
Second Trimester: Significant risk of fetal renal dysfunction, oligohydramnios, fetal lung hypoplasia, skeletal deformations, and death. Category D.
Third Trimester: Significant risk of fetal renal dysfunction, oligohydramnios, fetal lung hypoplasia, skeletal deformations, and death. Category D.
🤱

Lactation

Not recommended during breastfeeding. Both telmisartan and hydrochlorothiazide are excreted in human milk. Due to the potential for serious adverse reactions in the breastfed infant (e.g., hypotension, hyperkalemia, effects on renal function from telmisartan; electrolyte disturbances, decreased milk production from hydrochlorothiazide), a decision should be made whether to discontinue nursing or discontinue the drug, taking into account the importance of the drug to the mother.

Infant Risk: L3 (Moderate risk - potential for adverse effects on infant or milk supply)
👶

Pediatric Use

Safety and effectiveness have not been established in pediatric patients. Not recommended for use in children.

👴

Geriatric Use

No overall differences in effectiveness or safety have been observed between elderly and younger patients, but greater sensitivity of some older individuals cannot be ruled out. Start with lower doses and titrate carefully, monitoring renal function and electrolytes closely, as elderly patients are more likely to have age-related renal impairment.

Clinical Information

💎

Clinical Pearls

  • This combination is often used when monotherapy with an ARB or a thiazide diuretic is insufficient to control blood pressure.
  • Take consistently at the same time each day, preferably in the morning, to avoid nocturia (nighttime urination) due to the diuretic component.
  • Monitor for signs of orthostatic hypotension, especially at the start of therapy or with dose increases.
  • Educate patients on the importance of regular blood pressure monitoring at home.
  • Caution patients about the risk of hyperkalemia with telmisartan (an ARB) and hypokalemia with hydrochlorothiazide (a diuretic); regular electrolyte monitoring is crucial to manage these opposing effects.
  • Advise patients to report any signs of angioedema immediately, although rare with ARBs, it is a serious side effect.
  • Hydrochlorothiazide can increase uric acid levels and may precipitate gout attacks in susceptible individuals.
  • Hydrochlorothiazide can also cause photosensitivity; advise patients to use sun protection.
🔄

Alternative Therapies

  • Other classes of antihypertensives (e.g., ACE inhibitors, Calcium Channel Blockers, Beta-blockers, other diuretics)
  • Monotherapy with Telmisartan or Hydrochlorothiazide if blood pressure is adequately controlled.
💰

Cost & Coverage

Average Cost: Varies widely, typically $10-$50 per 30 tablets
Generic Available: Yes
Insurance Coverage: Tier 1 or Tier 2 (for generic)
📚

General Drug Facts

If your symptoms or health issues persist or worsen, it's essential to contact your doctor for further guidance. To ensure your safety, never share your medication with others or take someone else's medication. Some medications may come with an additional patient information leaflet, so be sure to check with your pharmacist for more information. If you have any questions or concerns about your medication, don't hesitate to reach out to your doctor, nurse, pharmacist, or other healthcare provider. In the event of a suspected overdose, immediately call your local poison control center or seek emergency medical attention. When seeking help, be prepared to provide details about the medication taken, the amount, and the time it happened.